Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Labeling Rule Should Be Tweaked, Firms Say; Dems Want It Squashed

Executive Summary

FDA appears to have a relatively smooth task ahead of itself as it works to finalize its proposed rule delineating when firms can change product labels without prior agency approval since the comments supporting the proposal contain few suggested changes
Advertisement

Related Content

No Dispute Over Safety-Related Label Updates; Does FDA Hold All The Cards?
No Dispute Over Safety-Related Label Updates; Does FDA Hold All The Cards?
FDA’s Office of Chief Counsel Is Growing Its Ranks As It Amends Its Act
FDA’s Office of Chief Counsel Is Growing Its Ranks As It Amends Its Act
FDA’s Off-Label Reprint Guidance Is Unlikely To Clarify Anything Very Soon
FDA Preemption Deadlocks Supreme Court; Congress Pushes To Resolve Issue
FDA Preemption: Agency’s Proposed Labeling Rule Riles Plaintiffs’ Bar
Federal Preemption Defense Against Product Liability Weakened In House Bill
FDA Adverse Event Rule Halted At OMB By Administration Regulation Freeze
FDA Adverse Event Rule Halted At OMB By Administration Regulation Freeze
Advertisement
UsernamePublicRestriction

Register

PS049507

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel